Print

Islet Sciences Begins Restructuring of Company’s Senior Management and Board of Directors  
7/17/2013 6:18:10 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Islet Sciences, Inc., (OTCBB:ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies for people with diabetes, today announced changes to the company’s senior management team and the board of directors.

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

//-->